1 Min Read
Aug 30 (Reuters) - Teva Pharmaceutical Industries Ltd
* Teva announces FDA approval of Austedo (deutetrabenazine) tablets for the treatment of tardive dyskinesia in adults Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.